Startseite>>Signaling Pathways>> GPCR/G protein>> CXCR>>ACT-1004-1239

ACT-1004-1239

Katalog-Nr.GC68618

ACT-1004-1239 ist ein wirksamer, selektiver und oral einzunehmender CXCR7-Antagonist mit einem IC50-Wert von 3,2 nM.

Products are for research use only. Not for human use. We do not sell to patients.

ACT-1004-1239 Chemische Struktur

Cas No.: 2178049-58-4

Größe Preis Lagerbestand Menge
5mg
585,00 $
Auf Lager
10mg
945,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Bewertungen

Review for ACT-1004-1239

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ACT-1004-1239

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.